A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects

Bioconjugate Chemistry

Volumn 21, Issue 3, 2010, Pages 436-444

  Kimura, Richard H ^a   Miao, Zheng ^a   Cheng, Zhen ^a   Gambhir, Sanjiv S ^a,b   Cochran, Jennifer R ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENCE IMAGING; INFRARED DEVICES; POSITRON EMISSION TOMOGRAPHY; TUMORS;

DIRECTED EVOLUTION; FLUORESCENCE EMISSION; IMAGING AGENT; INTEGRIN RECEPTORS; INTEGRINS; NEAR-INFRARED FLUORESCENCE; NEAR-INFRARED FLUORESCENCE IMAGING; TOMOGRAPHY IMAGING; TRYPSIN INHIBITOR; TUMOR MODELS;

PEPTIDES;

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID COPPER 64 CY5.5 KNOTTIN PEPTIDE CONJUGATE; ALPHAVBETA5 INTEGRIN; COPPER 64; FLUORESCENT DYE; INTEGRIN; TRYPSIN INHIBITOR; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; 1,4,7,10-TETRAAZACYCLODODECANE- 1,4,7,10-TETRAACETIC ACID; CARBOCYANINE; COPPER; CY5.5 CYANINE DYE; KNOTTIN; SINGLE HETEROCYCLIC RINGS;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; DRUG UPTAKE; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IMAGE DISPLAY; IMAGE QUALITY; MOLECULAR IMAGING; MOUSE; NEAR INFRARED FLUORESCENCE IMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; TUMOR; TUMOR XENOGRAFT; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; FEMALE; NEAR INFRARED SPECTROSCOPY; NEOPLASMS; NUDE MOUSE; PROCEDURES; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ECBALLIUM ELATERIUM;

ANIMALS; CARBOCYANINES; CELL LINE, TUMOR; COPPER RADIOISOTOPES; CYSTINE-KNOT MINIPROTEINS; FEMALE; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; MICE; MICE, NUDE; MOLECULAR IMAGING; MOLECULAR STRUCTURE; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; SPECTROSCOPY, NEAR-INFRARED; TISSUE DISTRIBUTION;

EID: 77949847038     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc9003102     Document Type: Article

References (34)

1. Hynes, R. O. (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69, 11-25.
2. Brooks, P. C., Clark, R. A., and Cheresh, D. A. (1994) Requirement of vascular integrin alphav beta3 for angiogenesis. Science 264, 569-571.
3. Friedender, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., and Cheresh, D. A. (1995) Definition of two angiogenic pathways by distinct alphav integrins. Science 270, 1500-1502.
4. Alghisi, G. C., and Ruegg, C. (2006) Vascular integrins in tumor angiogenesis: mediators and therapeutic targets. Endothelium 13, 113-135.
5. Mizejewski, G. J. (1999) Role of integrins in cancer: survey of expression patterns. Proc. Soc. Exn. Biol. Med. 222, 124-138.
6. Stupack, D. G., and Cheresh, D. A. (2004) Integrins and angiogenesis. Curr. Top. Dev. Biol. 64, 207-238.
7. Cai, W., Gambhir, S. S., and Chen, X. (2005) Multimodality tumor imaging targeting integrin alphav beta3. Biotechniques 39, S6-S17.
8. Cai, W., Rao, J., Gambhir, S. S., and Chen, X. (2006) How molecular imaging is speeding up antiangiogenic drug development. Mol. Cancer Ther. 5, 2624-2633.
9. Haubner, R. (2006) Alphav beta3-integrin imaging: a new approach to characterise angiogenesis? Eur. J. Nucl. Med. Mol. Imaging 33 (Suppl 1), 54-63.
10. Massoud, T. F., and Gambhir, S. S. (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 17, 545-580.
11. Rudin, M., and Weissleder, R. (2003) Molecular imaging in drug discovery and development. Nat. Rev. Drug. Discovery 2, 123-131.
12. Willmann, J. K., van Bruggen, N., Dinkelborg, L. M., and Gambhir, S.S. (2008) Molecular imaging in drug development. Nat. Ret. Drug. Discovery 7, 591-607.
13. Kimura, R. H., Levin, A. M., Cochran, F. V., and Cochran, J. R. (2009) Engineered cystine knot, peptides that, bind alphav beta3, alphav beta5, and alpha5 beta1 integrins with low nanomolar affinity. Proteins: Struct., Funct. Bioinf. 77, 359-369.
14. Cheng, Z., Wu, Y., Xiong, Z., Gambhir, S. S., and Chen, X. (2005) Near-infrared fluorescent. RGD peptides for optical imaging of integrin alphav beta3 expression in living mice. Bioconjugate Chem. 16, 1433-1441.
15. Kimura, R. H., Cheng, Z., Gambhir, S. S., and Cochran, J. R. (2009) Engineered knottin peptides: A new class of agents for imaging integrin expression in living subjects. Cancer Res. 69, 2435-2442.
16. Orlando, R. A., and Cheresh, D. A. (1991) Arginine-glycineaspartic acid binding leading to molecular stabilization between integrin alphav beta3 and its ligand. J. Biol. Chem. 266, 19543-19550.
17. 64Cu-labeled tetrameric RGD peptide. J. Nucl. Med. 46, 1707-1718.
18. Kumar, C. C., Nie, H., Rogers, C. P., Malkowski, M., Maxwell, E., Catino, J. J., and Armstrong, L. (1997) Biochemical characterization of the binding of echistatin to integrin alphav beta3 receptor. J. Pharmacol. Exp. Ther. 283, 843-853.
19. Bruning, A., and Runnebaum, I. B. (2003) CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone. TNFalpha. and TGFbeta. Gene Ther.10, 198-205.
20. Pfaff, M., McLane, M. A., Beviglia, L., Niewiarowski, S., and Timpl, R. (1994) Comparison of disintegrins with limited variation in the RGD loop in their binding to purified integrins alphaIIb beta3, alphav beta3 and alpha5 betal and in cell adhesion inhibition. Cell. Adhes. Commun. 2, 491-501.
21. 18F-FRGD2. J. Nucl. Med. 47, 113-121.
22. Wentzel, A., Christmann, A., Kratzner, R., and Kolmar, H. (1999) Sequence requirements of the GPNG beta-turn of the Ecballium elaterium trypsin inhibitor II explored by combinatorial library screening. J. Biol. Chem. 274, 21037-21043.
23. Simonsen, S. M., Daly, N. L., and Craik, D. J. (2004) Capped acyclic permutants of the circular protein kalata B1. FEBS Lett. 577, 399-402.
24. 111In-labelled DTPA- and DOTAconjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer. Eur. J. Nucl. Med. Mol. Imaging 30, 1134-1139.
25. Pless, J., Bauer, W., Briner, U., Doepfner, W., Marbach, P., Maurer, R., Petcher, T. J., Reubi, J. C., and Vonderscher, J. (1986) Chemistry and pharmacology of SMS 201-995, a longacting octapeptide analogue of somatostatin. Stand, J. Gastroenterol. Suppl. 119, 54-64.
26. Bhushan, K. R., Misra, P., Liu, F., Mathur, S., Lenkinski, R. E., and Frangioni, J. V. (2008) Detection of breast cancer microcalciflcations using a dual-modality SPECT/NIR fluorescent probe. J. Am. Chem. Soc. 130, 17648-17649.
27. Houston, J. P., Ke, S., Wang, W., Li, C., and Sevick-Muraca, E. M. (2005) Quality analysis of in vivo near-infrared fluorescence and conventional gamma images acquired using a duallabeled tumor-targeting probe. J. Biomed. Opt., 10, 054010.
28. Li, C., Wang, W., Wu, Q., Ke, S., Houston, J., Sevick-Muraca, E., Dong, L., Chow, D., Charnsangavej, C., and Gelovani, J. G. (2006) Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe. Nucl. Med. Biol. 33, 349-358.
29. Sampath, L., Kwon, S., Ke, S., Wang, W., Schiff, R., Mawad, M. E., and Sevick-Muraca, E. M. (2007) Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. J. Nucl. Med. 48, 1501-1510.
30. Wang, W., Ke, S., Kwon, S., Yallampalli, S., Cameron, A. G., Adams, K. E., Mawad, M. E., and Sevick-Muraca, E. M. (2007) A new optical and nuclear dual-labeled imaging agent targeting interleukin 11 receptor alpha-chain. Bioconjugate Chem. 18, 397-402.
31. Zhang, Z., Liang, K., Bloch, S., Berezin, M., and Achilefu, S. (2005) Monomolecular multimodal fluorescence-radioisotope imaging agents Bioconjugate Chem. 16, 1232-1239.
32. Lee, S., and Chen, X. (2009) Dual-modality probes for in vivo molecular imaging. Mol. Imaging 8, 87-100.
33. Cai, W., Chen, K., Li, Z. B., Gambhir, S. S., and Chen, X. (2007) Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature. J. Nucl. Med. 48, 1862-1870.
34. Chen, K., Li, Z. B., Wang, H., Cai, W., and Chen, X. (2008) Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots. Eur. J. Nucl. Med. Mol. Imaging 35, 2235-2244.